A Study to Learn About the First and Later Lines of Medicines in Treating People With Metastatic Renal Cell Carcinoma (mRCC).
Condition: Metastatic Renal Cell Carcinoma Intervention: Sponsor: Pfizer Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Carcinoma | Kidney Cancer | Learning | Pfizer | Renal Cell Carcinoma | Research | Study | Universities & Medical Training